Shattuck Labs Inc (NASDAQ: STTK) — Healthcare · Share Price, Chart & Market Data
About: Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study. It is also involved in the development of various preclinical DR3-based bispecific antibodies for the treatment of patients with inflammatory bowel disease or other immune-mediated indications; and TRIM7, an oncology-focused program. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Sector: Healthcare
Industry: Biotechnology
Latest price: $7.74 (+1.18%)
STTKShattuck Labs Inc
Loading watchlist status…
Trade STTK now
Shattuck Labs Inc share price
STTK price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:00 am GMT+0
STTK price performance
-0.258%
5D
28.571%
1M
108.625%
YTD
862.687%
1Y
STTK price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:00 am GMT+0
STTK details
STTK Market Signals